Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2021 | 665 | 0.54 | Why? |
| Coronary Disease | 1 | 2020 | 645 | 0.53 | Why? |
| Tomography, X-Ray Computed | 10 | 2021 | 25144 | 0.52 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.40 | Why? |
| CD3 Complex | 2 | 2020 | 237 | 0.39 | Why? |
| Diabetes Complications | 1 | 2020 | 2358 | 0.34 | Why? |
| Lung | 3 | 2021 | 31049 | 0.33 | Why? |
| Narrative Therapy | 1 | 2021 | 17 | 0.23 | Why? |
| Implosive Therapy | 1 | 2021 | 65 | 0.21 | Why? |
| Leukocyte Common Antigens | 1 | 2020 | 101 | 0.21 | Why? |
| Pneumonia, Viral | 12 | 2021 | 243684 | 0.21 | Why? |
| Horseradish Peroxidase | 1 | 2018 | 14 | 0.20 | Why? |
| Prealbumin | 1 | 2021 | 203 | 0.20 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.18 | Why? |
| Thyroxine | 1 | 2020 | 250 | 0.18 | Why? |
| Biomimetic Materials | 1 | 2018 | 70 | 0.18 | Why? |
| Glutathione | 1 | 2020 | 280 | 0.18 | Why? |
| Theranostic Nanomedicine | 1 | 2018 | 143 | 0.18 | Why? |
| Support Vector Machine | 1 | 2020 | 330 | 0.18 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.17 | Why? |
| Carcinoma, Non-Small-Cell Lung | 2 | 2017 | 896 | 0.17 | Why? |
| Oryza | 1 | 2018 | 86 | 0.17 | Why? |
| Phototherapy | 1 | 2018 | 138 | 0.16 | Why? |
| Speech Perception | 1 | 2018 | 132 | 0.15 | Why? |
| Nutrition Assessment | 1 | 2020 | 527 | 0.15 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.15 | Why? |
| Noise | 1 | 2018 | 194 | 0.15 | Why? |
| Age Factors | 4 | 2020 | 21039 | 0.15 | Why? |
| Perfusion Imaging | 1 | 2017 | 199 | 0.15 | Why? |
| ErbB Receptors | 1 | 2017 | 320 | 0.14 | Why? |
| Fever | 3 | 2020 | 7795 | 0.14 | Why? |
| Hearing Loss | 1 | 2018 | 225 | 0.14 | Why? |
| Image Processing, Computer-Assisted | 2 | 2020 | 1383 | 0.14 | Why? |
| China | 8 | 2020 | 50654 | 0.13 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.13 | Why? |
| Lymphocyte Subsets | 1 | 2020 | 987 | 0.13 | Why? |
| Leukocyte Count | 2 | 2020 | 3178 | 0.12 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.12 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.11 | Why? |
| Adult | 15 | 2021 | 244371 | 0.11 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.11 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.11 | Why? |
| Adjuvants, Immunologic | 1 | 2020 | 1709 | 0.11 | Why? |
| Female | 18 | 2021 | 380317 | 0.10 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.10 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.10 | Why? |
| Nutritional Status | 1 | 2020 | 1403 | 0.10 | Why? |
| Lung Neoplasms | 2 | 2017 | 3228 | 0.10 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.10 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.10 | Why? |
| Male | 16 | 2021 | 367725 | 0.09 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.09 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.09 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.08 | Why? |
| Cognitive Dysfunction | 1 | 2018 | 1389 | 0.08 | Why? |
| Cough | 1 | 2020 | 4891 | 0.08 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.07 | Why? |
| Humans | 21 | 2021 | 930598 | 0.07 | Why? |
| Length of Stay | 2 | 2021 | 11042 | 0.07 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.07 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2021 | 2963 | 0.07 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.06 | Why? |
| Aged | 10 | 2021 | 215776 | 0.06 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.06 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| HIV Infections | 2 | 2018 | 11620 | 0.06 | Why? |
| Young Adult | 6 | 2020 | 93724 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2018 | 3633 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.05 | Why? |
| Neoplasm Staging | 2 | 2017 | 1999 | 0.05 | Why? |
| Mammary Neoplasms, Experimental | 1 | 2018 | 21 | 0.05 | Why? |
| Photoacoustic Techniques | 1 | 2018 | 31 | 0.05 | Why? |
| Granulocytes | 1 | 2020 | 140 | 0.05 | Why? |
| Acoustic Impedance Tests | 1 | 2018 | 16 | 0.05 | Why? |
| Audiometry | 1 | 2018 | 30 | 0.05 | Why? |
| Perceptual Masking | 1 | 2018 | 16 | 0.05 | Why? |
| Leukocytosis | 1 | 2020 | 280 | 0.04 | Why? |
| Gadolinium | 1 | 2018 | 318 | 0.04 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.04 | Why? |
| Health Status Indicators | 1 | 2020 | 341 | 0.04 | Why? |
| Pandemics | 10 | 2020 | 389249 | 0.04 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.04 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Nutritional Support | 1 | 2020 | 447 | 0.04 | Why? |
| Tumor Burden | 1 | 2017 | 369 | 0.04 | Why? |
| Imaging, Three-Dimensional | 1 | 2020 | 680 | 0.04 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.03 | Why? |
| Blood Cell Count | 1 | 2020 | 1101 | 0.03 | Why? |
| C-Reactive Protein | 2 | 2021 | 7972 | 0.03 | Why? |
| Mutation Rate | 1 | 2017 | 382 | 0.03 | Why? |
| Gene Frequency | 1 | 2018 | 1210 | 0.03 | Why? |
| Hydrogen Peroxide | 1 | 2018 | 680 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2020 | 11304 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Linear Models | 1 | 2018 | 1914 | 0.03 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 952 | 0.03 | Why? |
| Nanostructures | 1 | 2018 | 700 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2018 | 1648 | 0.03 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.03 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.02 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.02 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.02 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.02 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
Shi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(178)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_